Eagle Rock Investment Company’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Eagle Rock Investment Company’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-42,000	Closed	-$40.2K	–	132
2023 Q2	$40.2K	Hold	42,000	–	–	0.01%	128
2023 Q1	$29.4K	Hold	42,000	–	–	0.01%	125
2022 Q4	$41.2K	Buy	42,000 +20,000	+91%	+$19.7K	0.01%	135
2022 Q3	$23K	Sell	22,000 -22,000	-50%	-$35.2K	0.01%	122
2022 Q2	$72K	Buy	44,000 +22,000	+100%	+$45.7K	0.02%	121
2022 Q1	$65K	Hold	22,000	–	–	0.01%	113
2021 Q4	$105K	Buy	+22,000	New	+$142K	0.02%	103

Eagle Rock Investment Company's SURF Position: Q3 2023 in Review

Eagle Rock Investment Company sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 42,000 shares — an estimated $40.2K sold.

Eagle Rock Investment Company first reported a position in SURF in Q4 2021 and held it in 7 quarters. The position peaked at $105K in Q4 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

Eagle Rock Investment Company reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Eagle Rock Investment Company sold 42,000 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $40.2K.
Eagle Rock Investment Company first reported a position in Surface Oncology, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Eagle Rock Investment Company's Surface Oncology, Inc. Common Stock position peaked at $105K in Q4 2021.
0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Eagle Rock Investment Company's 13F filing for Q3 2023, filed 10 Oct 2023.